Cargando…

Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology

Human prion diseases are fatal neurodegenerative disorders with a genetic, sporadic or infectiously acquired aetiology. Neuropathologically, human prion diseases are characterized by deposition of misfolded prion protein and neuronal loss. In post-mortem brain tissue from patients with other neurode...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiersma, Vera I., van Hecke, Wim, Scheper, Wiep, van Osch, Martijn A. J., Hermsen, Will J. M., Rozemuller, Annemieke J. M., Hoozemans, Jeroen J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086055/
https://www.ncbi.nlm.nih.gov/pubmed/27793194
http://dx.doi.org/10.1186/s40478-016-0383-7
_version_ 1782463674137444352
author Wiersma, Vera I.
van Hecke, Wim
Scheper, Wiep
van Osch, Martijn A. J.
Hermsen, Will J. M.
Rozemuller, Annemieke J. M.
Hoozemans, Jeroen J. M.
author_facet Wiersma, Vera I.
van Hecke, Wim
Scheper, Wiep
van Osch, Martijn A. J.
Hermsen, Will J. M.
Rozemuller, Annemieke J. M.
Hoozemans, Jeroen J. M.
author_sort Wiersma, Vera I.
collection PubMed
description Human prion diseases are fatal neurodegenerative disorders with a genetic, sporadic or infectiously acquired aetiology. Neuropathologically, human prion diseases are characterized by deposition of misfolded prion protein and neuronal loss. In post-mortem brain tissue from patients with other neurodegenerative diseases characterized by protein misfolding, including Alzheimer’s disease (AD) and frontotemporal lobar degeneration with tau pathology (FTLD-tau), increased activation of the unfolded protein response (UPR) has been observed. The UPR is a cellular stress response that copes with the presence of misfolded proteins. Recent studies have indicated that UPR activation is also involved in experimental models of prion disease and have suggested intervention in the UPR as a therapeutic strategy. On the other hand, it was previously shown that the active form of the UPR stress sensor dsRNA-activated protein kinase-like ER kinase (PERK) is not increased in post-mortem brain tissue samples from human prion disease cases. In the present study, we assessed the active form of another UPR stress sensor, inositol-requiring enzyme 1α (IRE1α), in human post-mortem frontal cortex of a large cohort of sporadic, inherited and acquired prion disease patients (n = 47) and non-neurological controls. Immunoreactivity for phosphorylated IRE1α was not increased in prion disease cases compared with non-neurological controls. In addition, immunoreactivity for phosphorylated PERK was unaltered in human prion disease cases included in the current cohort. Moreover, no difference in the extent of granulovacuolar degeneration, a pathological feature associated with the presence of UPR activation markers, was detected. Our data indicate that, in contrast to AD and primary tauopathies, activation of the UPR is not a common feature of human prion pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0383-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5086055
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50860552016-10-31 Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology Wiersma, Vera I. van Hecke, Wim Scheper, Wiep van Osch, Martijn A. J. Hermsen, Will J. M. Rozemuller, Annemieke J. M. Hoozemans, Jeroen J. M. Acta Neuropathol Commun Research Human prion diseases are fatal neurodegenerative disorders with a genetic, sporadic or infectiously acquired aetiology. Neuropathologically, human prion diseases are characterized by deposition of misfolded prion protein and neuronal loss. In post-mortem brain tissue from patients with other neurodegenerative diseases characterized by protein misfolding, including Alzheimer’s disease (AD) and frontotemporal lobar degeneration with tau pathology (FTLD-tau), increased activation of the unfolded protein response (UPR) has been observed. The UPR is a cellular stress response that copes with the presence of misfolded proteins. Recent studies have indicated that UPR activation is also involved in experimental models of prion disease and have suggested intervention in the UPR as a therapeutic strategy. On the other hand, it was previously shown that the active form of the UPR stress sensor dsRNA-activated protein kinase-like ER kinase (PERK) is not increased in post-mortem brain tissue samples from human prion disease cases. In the present study, we assessed the active form of another UPR stress sensor, inositol-requiring enzyme 1α (IRE1α), in human post-mortem frontal cortex of a large cohort of sporadic, inherited and acquired prion disease patients (n = 47) and non-neurological controls. Immunoreactivity for phosphorylated IRE1α was not increased in prion disease cases compared with non-neurological controls. In addition, immunoreactivity for phosphorylated PERK was unaltered in human prion disease cases included in the current cohort. Moreover, no difference in the extent of granulovacuolar degeneration, a pathological feature associated with the presence of UPR activation markers, was detected. Our data indicate that, in contrast to AD and primary tauopathies, activation of the UPR is not a common feature of human prion pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0383-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-28 /pmc/articles/PMC5086055/ /pubmed/27793194 http://dx.doi.org/10.1186/s40478-016-0383-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wiersma, Vera I.
van Hecke, Wim
Scheper, Wiep
van Osch, Martijn A. J.
Hermsen, Will J. M.
Rozemuller, Annemieke J. M.
Hoozemans, Jeroen J. M.
Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
title Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
title_full Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
title_fullStr Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
title_full_unstemmed Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
title_short Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
title_sort activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086055/
https://www.ncbi.nlm.nih.gov/pubmed/27793194
http://dx.doi.org/10.1186/s40478-016-0383-7
work_keys_str_mv AT wiersmaverai activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology
AT vanheckewim activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology
AT scheperwiep activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology
AT vanoschmartijnaj activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology
AT hermsenwilljm activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology
AT rozemullerannemiekejm activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology
AT hoozemansjeroenjm activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology